Expected Moves

The Read: LENSAR’s stock historically plunged over 50% when its Alcon acquisition failed due to FTC challenges and regulatory delays, briefly rallied on strong ALLY system placements and backlogs, but then declined sharply after disappointing deal terms and NASDAQ delisting before modestly recovering on a standalone strategic update.